A phase II single-arm study of low-dose nivolumab as neoadjuvant therapy in microsatellite instability-high locally advanced rectal cancer (ESMO-IO 2026) - Oct 25, 2026 - Abstract #252TiP; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clinical • Metastases • MSI-H • P2 data • Colorectal Cancer • Microsatellite Instability • Oncology • Rectal Cancer • Solid Tumor • MSI
|
|
Vikas S. Ostwal; Akhil Kapoor; Anuradha Mehta; George John; Ashwin De Souza; M ufaddal Kazi; Rajiv K. Kaushal; Subhas h Yadav; Gauri Deshpande; Purvi Anand; Akshay Baheti; Omshree Shetty; Anant Ramaswamy; Prabhat G. Bhargava
|